WallStSmart

Medical Properties Trust, Inc. (MPT)vsVentas Inc (VTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 456% more annual revenue ($6.11B vs $1.10B). VTR leads profitability with a 4.3% profit margin vs -11.5%. MPT appears more attractively valued with a PEG of 1.61. MPT earns a higher WallStSmart Score of 55/100 (C).

MPT

Buy

55

out of 100

Grade: C

Growth: 4.0Profit: 4.5Value: 4.7Quality: 4.5
Piotroski: 2/9Altman Z: 0.11

VTR

Buy

51

out of 100

Grade: C-

Growth: 7.3Profit: 4.5Value: 3.3Quality: 4.0
Piotroski: 4/9Altman Z: 0.43
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MPT.

VTROvervalued (-9.8%)

Margin of Safety

-9.8%

Fair Value

$77.07

Current Price

$79.09

$2.02 premium

UndervaluedFair: $77.07Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MPT2 strengths · Avg: 10.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

Operating MarginProfitability
58.2%10/10

Strong operational efficiency at 58.2%

VTR2 strengths · Avg: 8.0/10
Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
21.9%8/10

Revenue surging 21.9% year-over-year

Areas to Watch

MPT4 concerns · Avg: 3.3/10
PEG RatioValuation
1.614/10

Expensive relative to growth rate

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-2.7%2/10

ROE of -2.7% — below average capital efficiency

VTR4 concerns · Avg: 3.0/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Return on EquityProfitability
2.0%3/10

ROE of 2.0% — below average capital efficiency

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

P/E RatioValuation
153.8x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : MPT

The strongest argument for MPT centers on Price/Book, Operating Margin. Revenue growth of 12.6% demonstrates continued momentum.

Bull Case : VTR

The strongest argument for VTR centers on Price/Book, Revenue Growth. Revenue growth of 21.9% demonstrates continued momentum.

Bear Case : MPT

The primary concerns for MPT are PEG Ratio, EPS Growth, Piotroski F-Score. Debt-to-equity of 2.15 is elevated, increasing financial risk.

Bear Case : VTR

The primary concerns for VTR are PEG Ratio, Return on Equity, Profit Margin. A P/E of 153.8x leaves little room for execution misses. Thin 4.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

MPT profiles as a turnaround stock while VTR is a growth play — different risk/reward profiles.

MPT carries more volatility with a beta of 1.46 — expect wider price swings.

VTR is growing revenue faster at 21.9% — sustainability is the question.

MPT generates stronger free cash flow (-14M), providing more financial flexibility.

Bottom Line

MPT scores higher overall (55/100 vs 51/100) and 12.6% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medical Properties Trust, Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Medical Properties Trust, Inc. is a self-advised real estate investment trust to acquire and develop net-leased hospital facilities.

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Want to dig deeper into these stocks?